p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma
Hur, S. K.; Somerville, T. D. D.; Wu, X. S.; Maia-Silva, D.; Demerdash, O. E.; Tuveson, D. A.; Notta, F.; Vakoc, C. R.
Show abstract
During the progression of pancreatic ductal adenocarcinoma (PDAC), tumor cells are known to acquire transcriptional and morphological properties of the basal (also known as squamous) epithelial lineage, which leads to more aggressive disease characteristics. Here, we show that a subset of basal-like PDAC tumors aberrantly express p73 (TA isoform), which is a known transcriptional activator of basal lineage identity, ciliogenesis, and tumor suppression in normal tissue development. Using gain- and loss- of function experiments, we show that p73 is necessary and sufficient to activate genes related to basal identity (e.g. KRT5), ciliogenesis (e.g. FOXJ1), and p53-like tumor suppression (e.g. CDKN1A) in human PDAC models. Owing to the paradoxical combination of oncogenic and tumor suppressive outputs of this transcription factor, we propose that PDAC cells express a low level of p73 that is optimal for promoting lineage plasticity without severe impairment of cell proliferation. Collectively, our study reinforces how PDAC cells exploit master regulators of the basal epithelial lineage during disease progression.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation 95%
- An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma 95%
- An epigenetic switch regulates the ontogeny of AXL positive/EGFR-TKI resistant cells by modulating miR-335 expression 94%
Similar papers in this journal
- Gα13 loss promotes tumor progression in the KPC transgenic mouse model of advanced pancreatic cancer 95%
- Genetic Impairment of Succinate Metabolism Disrupts Bioenergetic Sensing in Adrenal Neuroendocrine Cancer 94%
- A multiplexed in vivo approach to identify driver genes in small cell lung cancer 93%
Similar papers in this journal
Similar papers in this journal
- USP28 enables oncogenic transformation of respiratory cells and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. 93%
- Targeting LDHC dysregulates the cell cycle and improves sensitivity to cisplatin and olaparib 92%
- Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance. 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.